Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Interest Income | 135,929 | 148,768 | 154,519 | 160,131 | 169,110 |
| Interest Expense | 54,978 | 61,709 | 66,900 | 71,783 | 85,772 |
| Interest Income (Net of Interest Expense) | 80,951 | 87,059 | 87,619 | 88,348 | 83,338 |
| Non-Interest Income | 28,065 | 27,431 | 31,692 | 36,626 | 22,216 |
| Sales | 109,016 | 114,490 | 119,311 | 124,974 | 105,554 |
| Credit Losses Provision | 340,257 | 195,505 | 79,744 | 65,865 | 228,517 |
| Non Interest Expenses | 94,470 | 317,925 | 105,149 | 79,988 | 313,208 |
| Pre-tax Income | -325,711 | -398,940 | -65,582 | -20,879 | -436,171 |
| Income Tax | 3,000 | 60,467 | -36,049 | -436 | -81,088 |
| Other Income | -270,733 | -337,231 | 1,318 | 50,904 | -350,399 |
| Net Income | $-328,711 | $-459,407 | $-29,533 | $-20,443 | $-355,083 |
| EPS Basic Continuous Ops | -419.49 | -582.10 | -37.42 | -25.92 | -452.85 |
| EPS Basic Total Ops | -425.57 | -587.50 | -42.76 | -31.58 | -455.36 |
| EPS Diluted Continuous Ops | -419.49 | -582.10 | -37.42 | -25.92 | -452.76 |
| EPS Diluted Total Ops | -425.57 | -587.50 | -42.76 | -31.58 | -455.36 |
| EBITDA(a) | $N/A | $N/A | $N/A | $N/A | $N/A |